p38 Mitogen-Activated Protein Kinase-γ Inhibition by Long-Acting β2Adrenergic Agonists Reversed Steroid Insensitivity in Severe Asthma
- 14 September 2011
- journal article
- research article
- Published by American Society for Pharmacology & Experimental Therapeutics (ASPET) in Molecular Pharmacology
- Vol. 80 (6), 1128-1135
- https://doi.org/10.1124/mol.111.071993
Abstract
Corticosteroid insensitivity (CI) is a major barrier to treating severe asthma. Despite intensive research, the molecular mechanism of CI remains uncertain. The aim of this study was to determine abnormality in corticosteroid action in severe asthma and to identify the molecular mechanism of the long-acting β2-adrenergic agonists (LABAs) formoterol and salmeterol on restoration of corticosteroid sensitivity in severe asthma in vitro. Peripheral blood mononuclear cells (PBMCs) were obtained from 16 subjects with severe corticosteroid-insensitive asthma, 6 subjects with mild corticosteroid-sensitive asthma, and 11 healthy volunteers. Corticosteroid (dexamethasone) sensitivity was determined on tumor necrosis factor-α (TNF-α)-induced interleukin (IL)-8 production. Glucocorticoid receptor (GR) phosphorylation and kinase phosphorylation were evaluated by immunoprecipitation-Western blotting analysis and kinase phosphorylation array in IL-2/IL-4-treated corticosteroid insensitive model in PBMCs. In vitro corticosteroid sensitivity on TNF-α-induced IL-8 production was significantly lower in patients with severe asthma than in healthy volunteers and patients with mild asthma. This CI seen in severe asthma was associated with reduced GR nuclear translocation and with hyperphosphorylation of GR, which were reversed by LABAs. In IL-2/IL-4-treated PBMCs, LABAs inhibited phosphorylation of Jun-NH2-terminal kinase and p38 mitogen-activated protein kinase-γ (p38MAPK-γ) as well as GR. In addition, cells with p38MAPK-γ knockdown by RNA interference did not develop CI in the presence of IL-2/IL-4. Furthermore, p38MAPK-γ protein expression was up-regulated in PBMCs from some patients with severe asthma. In conclusion, p38 MAPK-γ activation impairs corticosteroid action and p38 MAPK-γ inhibition by LABAs has potential for the treatment of severe asthma.Keywords
This publication has 33 references indexed in Scilit:
- Protein phosphatase 5The International Journal of Biochemistry & Cell Biology, 2007
- Relative Corticosteroid Insensitivity of Peripheral Blood Mononuclear Cells in Severe AsthmaAmerican Journal of Respiratory and Critical Care Medicine, 2006
- Histone deacetylase 2–mediated deacetylation of the glucocorticoid receptor enables NF-κB suppressionThe Journal of Experimental Medicine, 2005
- Inhaled Salmeterol/Fluticasone PropionateDrugs, 2005
- Defective glucocorticoid receptor nuclear translocation and altered histone acetylation patterns in glucocorticoid-resistant patientsJournal of Allergy and Clinical Immunology, 2004
- Modulation of Glucocorticoid Receptor Function via PhosphorylationAnnals of the New York Academy of Sciences, 2004
- Steroid resistance in asthma: a major problem requiring novel solutions or a non-issue?Current Opinion in Pharmacology, 2004
- Glucocorticoid Receptor Recruitment of Histone Deacetylase 2 Inhibits Interleukin-1β-Induced Histone H4 Acetylation on Lysines 8 and 12Molecular and Cellular Biology, 2000
- Ligand-independent Activation of the Glucocorticoid Receptor by β2-Adrenergic Receptor Agonists in Primary Human Lung Fibroblasts and Vascular Smooth Muscle CellsPublished by Elsevier BV ,1999
- SAP kinase‐3, a new member of the family of mammalian stress‐activated protein kinasesFEBS Letters, 1996